Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease.

Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lütjohann D, Nitsch RM, Hock C.

J Clin Psychiatry. 2005 Jul;66(7):940-7.

PMID:
16013913
2.

CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism.

Kölsch H, Lütjohann D, Jessen F, Popp J, Hentschel F, Kelemen P, Schmitz S, Maier W, Heun R.

Eur Psychiatry. 2009 Apr;24(3):183-90. doi: 10.1016/j.eurpsy.2008.12.005. Epub 2009 Mar 16.

PMID:
19286353
3.

Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease.

Desai P, DeKosky ST, Kamboh MI.

Neurosci Lett. 2002 Aug 2;328(1):9-12.

PMID:
12123847
4.

Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.

Fernández Del Pozo V, Alvarez Alvarez M, Fernández Martínez M, Galdós Alcelay L, Gómez Busto F, Peña JA, Alfonso-Sánchez MA, Zarranz Imirizaldu JJ, de Pancorbo MM.

Dement Geriatr Cogn Disord. 2006;21(2):81-7. Epub 2005 Dec 9.

5.

In this issue: genetics, cholesterol, and the risk of Alzheimer's disease.

Reiman EM.

J Clin Psychiatry. 2005 Jul;66(7):938-9. No abstract available.

6.

The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.

Vega GL, Weiner M, Kölsch H, von Bergmann K, Heun R, Lutjohan D, Nguyen A, Moore C.

Curr Alzheimer Res. 2004 Feb;1(1):71-7.

PMID:
15975088
7.

Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.

Kölsch H, Lütjohann D, Ludwig M, Schulte A, Ptok U, Jessen F, von Bergmann K, Rao ML, Maier W, Heun R.

Mol Psychiatry. 2002;7(8):899-902.

8.

Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.

Kabbara A, Payet N, Cottel D, Frigard B, Amouyel P, Lambert JC.

Neurosci Lett. 2004 Jun 10;363(2):139-43.

PMID:
15172102
9.

CYP46A1 functional promoter haplotypes decipher genetic susceptibility to Alzheimer's disease.

Li Y, Chu LW, Wang B, Yik PY, Huriletemuer, Jin DY, Ma X, Song YQ.

J Alzheimers Dis. 2010;21(4):1311-23. doi: 10.3233/JAD-2010-100765. Erratum in: J Alzheimers Dis. 2011;27(2):463.

PMID:
20693622
10.

Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese.

Wang B, Zhang C, Zheng W, Lu Z, Zheng C, Yang Z, Wang L, Jin F.

Neurosci Lett. 2004 Oct 14;369(2):104-7.

PMID:
15450677
11.

Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12.

Luedecking-Zimmer E, DeKosky ST, Chen Q, Barmada MM, Kamboh MI.

Hum Genet. 2002 Oct;111(4-5):443-51. Epub 2002 Aug 16.

PMID:
12384789
12.

ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.

Macé S, Cousin E, Ricard S, Génin E, Spanakis E, Lafargue-Soubigou C, Génin B, Fournel R, Roche S, Haussy G, Massey F, Soubigou S, Bréfort G, Benoit P, Brice A, Campion D, Hollis M, Pradier L, Benavides J, Deleuze JF.

Neurobiol Dis. 2005 Feb;18(1):119-25.

PMID:
15649702
13.

Cyp46 polymorphisms in Alzheimer's disease: a review.

Garcia AN, Muniz MT, Souza e Silva HR, da Silva HA, Athayde-Junior L.

J Mol Neurosci. 2009 Nov;39(3):342-5. doi: 10.1007/s12031-009-9227-2. Epub 2009 Aug 25. Review.

PMID:
19705089
14.
15.

Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease.

Tedde A, Rotondi M, Cellini E, Bagnoli S, Muratore L, Nacmias B, Sorbi S.

Neurobiol Aging. 2006 May;27(5):773.e1-773.e3. Epub 2005 Aug 1.

PMID:
16055229
16.

Lack of association between the brain-derived neurotrophin factor (C-270T) polymorphism and late-onset Alzheimer's disease (LOAD) in Brazilian patients.

Nishimura AL, Oliveira JR, Mitne-Neto M, Guindalini C, Nitrini R, Bahia VS, de Brito-Marques PR, Otto PA, Zatz M.

J Mol Neurosci. 2004;22(3):257-60.

PMID:
14997020
17.

Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.

Reiman EM, Chen K, Caselli RJ, Alexander GE, Bandy D, Adamson JL, Lee W, Cannon A, Stephan EA, Stephan DA, Papassotiropoulos A.

Neuroimage. 2008 Apr 15;40(3):1214-21. doi: 10.1016/j.neuroimage.2007.12.066. Epub 2008 Jan 17.

18.

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.

Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, Lütjohann D, Ghebremedhin E, Hegi T, Pasch T, Träxler M, Brühl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C.

Arch Neurol. 2003 Jan;60(1):29-35.

PMID:
12533085
19.

No association between a previously reported OLR1 3' UTR polymorphism and Alzheimer's disease in a large family sample.

Bertram L, Parkinson M, Mullin K, Menon R, Blacker D, Tanzi RE.

J Med Genet. 2004 Apr;41(4):286-8. No abstract available.

20.

Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels.

Fourgeux C, Martine L, Björkhem I, Diczfalusy U, Joffre C, Acar N, Creuzot-Garcher C, Bron A, Bretillon L.

Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5712-7. doi: 10.1167/iovs.09-3655. Epub 2009 Jun 24.

PMID:
19553612

Supplemental Content

Support Center